Protalix BioTherapeutics (PLX) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.42% |
| Dec 31, 2025 | 13.86% |
| Sep 30, 2025 | 13.20% |
| Jun 30, 2025 | 8.98% |
| Mar 31, 2025 | 2.61% |
| Dec 31, 2024 | -0.11% |
| Sep 30, 2024 | -9.65% |
| Jun 30, 2024 | -5.42% |
| Mar 31, 2024 | -4.40% |
| Dec 31, 2023 | 7.52% |
| Sep 30, 2023 | 6.59% |
| Jun 30, 2023 | 7.23% |
| Mar 31, 2023 | -7.05% |
| Dec 31, 2022 | 7.12% |
| Sep 30, 2022 | 1.82% |
| Jun 30, 2022 | 3.16% |
| Mar 31, 2022 | 3.86% |
| Dec 31, 2021 | 6.41% |
| Sep 30, 2021 | 8.29% |
| Jun 30, 2021 | 27.90% |
| Mar 31, 2021 | 16.63% |
| Dec 31, 2020 | -2.02% |
| Sep 30, 2020 | 5.80% |
| Jun 30, 2020 | 6.72% |
| Mar 31, 2020 | 4.87% |
| Dec 31, 2019 | -17.97% |
| Sep 30, 2019 | -8.65% |
| Jun 30, 2019 | -11.19% |
| Mar 31, 2019 | -11.24% |
| Dec 31, 2018 | -14.34% |
| Dec 31, 2017 | -2.68% |
| Mar 31, 2017 | -11.43% |
| Dec 31, 2016 | -10.14% |
| Sep 30, 2016 | -16.52% |
| Jun 30, 2016 | 8.17% |
| Mar 31, 2016 | 7.67% |
| Dec 31, 2015 | 7.30% |
| Dec 31, 2014 | 14.79% |
| Dec 31, 2013 | 20.53% |